Professor Sean Tu Leads JAMA Study on Drug Patents and Generic Competition
Professor of Law S. Sean Tu is the lead author of a new study, published Sept. 28 in JAMA, that examines the patent portfolios of every FDA-approved small-molecule drug over a 30-year period. The article, “Patents on Small-Molecule Drugs Approved by the US Food and Drug Administration, 1990-2019,” brings together researchers from the University of…